Trial · NCT02025179
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Bone Mineral Density (BMD) of the Total Hip as Assessed by Dual-energy X-ray Absorptiometry (DXA) | Teriparatide | 6.73 | 95% Confidence Interval 3.37 to 10.1 | Percent change | |
| Bone Mineral Density (BMD) of the Total Hip as Assessed by Dual-energy X-ray Absorptiometry (DXA) | Vibration | -0.34 | 95% Confidence Interval -3.50 to 2.82 | Percent change | |
| Bone Mineral Density (BMD) of the Total Hip as Assessed by Dual-energy X-ray Absorptiometry (DXA) | Teriparatide and Vibration | 4.24 | 95% Confidence Interval 0.37 to 8.11 | Percent change | |
| C-terminal Telopeptide | Teriparatide | -19.8 | 95% Confidence Interval -69.0 to 29.5 | Percent change | |
| C-terminal Telopeptide | Vibration | -14.8 | 95% Confidence Interval -61.2 to 31.6 | Percent change | |
| C-terminal Telopeptide | Teriparatide and Vibration | -2.12 | 95% Confidence Interval -54.8 to 50.5 | Percent change | |
| Bone Mineral Density (BMD) by DXA at the Lumbar Spine | Teriparatide | 14.4 | 95% Confidence Interval 11.0 to 17.8 | Percent change | |
| Bone Mineral Density (BMD) by DXA at the Lumbar Spine | Vibration | 7.05 | 95% Confidence Interval 3.87 to 10.2 | Percent change | |
| Bone Mineral Density (BMD) by DXA at the Lumbar Spine | Teriparatide and Vibration | 8.98 | 95% Confidence Interval 5.08 to 12.9 | Percent change | |
| Bone Mineral Density (BMD) by DXA at Femoral Neck | Teriparatide | 2.73 | 95% Confidence Interval -2.81 to 8.26 | Percent change | |
| Bone Mineral Density (BMD) by DXA at Femoral Neck | Vibration | -0.06 | 95% Confidence Interval -5.28 to 5.16 | Percent change | |
| Bone Mineral Density (BMD) by DXA at Femoral Neck | Teriparatide and Vibration | 4.71 | 95% Confidence Interval -1.20 to 10.6 | Percent change | |
| Amino-terminal Propeptide of Type 1 Collagen | Teriparatide | 102 | 95% Confidence Interval 73 to 132 | Percent change | |
| Amino-terminal Propeptide of Type 1 Collagen | Vibration | 104 | 95% Confidence Interval 76.6 to 132 | Percent change | |
| Amino-terminal Propeptide of Type 1 Collagen | Teriparatide and Vibration | 58 | 95% Confidence Interval 26.6 to 89.5 | Percent change | |
| Bone-specific Alkaline Phosphatase | Teriparatide | 11.5 | 95% Confidence Interval 9.04 to 14.0 | Percent change | |
| Bone-specific Alkaline Phosphatase | Vibration | 12.6 | 95% Confidence Interval 10.3 to 14.9 | Percent change | |
| Bone-specific Alkaline Phosphatase | Teriparatide and Vibration | 10.9 | 95% Confidence Interval 8.30 to 13.6 | Percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02025179/results